← back to search

Rishi P. Singh

Massachusetts Eye and Ear Infirmary · US
Area of research
Ophthalmology · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Retinal Diseases and Treatments, Retinal Imaging and Analysis, Retinal and Optic Conditions, and Retinal and Macular Surgery.
h-index
48
citations
12,963
works
586
NIH funding
primary concept
Medicine
email

Recent publications

Characteristics and Outcomes of Patients with Neovascular Age-Related Macular Degeneration by Anti-VEGF Exposure in United States Clinical Practice
Ophthalmology Retina 2026cited by 1position: contributordoi
Incidence, Prevalence, and Risk of Retinal Detachment and Tears Up to 10 Years After Phacoemulsification in a Large US Cohort.
2026cited by 0position: contributordoi
Association between ocular manifestations and incident cardiovascular comorbidities in Ehlers Danlos Syndrome.
2026cited by 0position: contributordoi
Real-World Data on Treatment Compliance and Visual Outcomes Between Patients With Diabetic Macular Edema or Retinal Vein Occlusion Receiving Antivascular Endothelial Growth Factor Injections or Intravitreal Corticosteroid Implants.
2026cited by 0position: contributordoi
Visual Acuity and Durability Outcomes of Faricimab Compared With Other Anti-vascular Endothelial Growth Factor Agents Within Routine Clinical Practice for Diabetic Macular Edema.
2026cited by 0position: contributordoi
Visual Acuity and Durability Outcomes of Faricimab Compared With Other Antivascular Endothelial Growth Factor Agents Within Routine Clinical Practice for Neovascular Age-Related Macular Degeneration.
2026cited by 0position: contributordoi
Establishing Expert Consensus on a Unified Decision Framework for Retina Patient Care.
2026cited by 0position: contributordoi
Associations between Systemic Tyrosine Kinase Inhibitors and Development of Age-Related Macular Degeneration in Patients with Cancer
Ophthalmology Retina 2026cited by 0position: contributordoi
The Effect of Semaglutide and GLP-1 RAs on Risk of Nonarteritic Anterior Ischemic Optic Neuropathy.
2025cited by 28position: contributordoi
Exploring new horizons in neovascular age-related macular degeneration: novel mechanisms of action and future therapeutic avenues.
2025cited by 12position: contributordoi
Risk of audiologic side effects with teprotumumab treatment for thyroid eye disease: propensity matched analysis.
2025cited by 5position: contributordoi
Prevalence of pediatric and adult optic neuritis in the United States from 2016 to 2023.
2025cited by 3position: contributordoi
Evaluation of Sustained Intraocular Pressure Elevations Across Antivascular Endothelial Growth Factor Agents.
2025cited by 2position: contributordoi
Associations between obstructive sleep apnoea and the development and severity of retinal vein occlusion.
2025cited by 1position: contributordoi
Impact of Duration of Exposure to Intraretinal Fluid on Visual Outcomes in Neovascular Age-Related Macular Degeneration
Ophthalmology Retina 2025cited by 1position: contributordoi
Reply to age inaccuracies in an epidemiological study of paediatric and adult optic neuritis.
2025cited by 0position: contributordoi
Consideration of patient phenotypes in geographic atrophy due to age-related macular degeneration.
2025cited by 0position: contributordoi
Response to 'comment on 'characterization and prevalence of ocular comorbidities and risk of legal blindness across the United States''.
2025cited by 0position: contributordoi
Trends and Disparities in the Incidence and Prevalence of Inherited Retinal Diseases in the United States.
2025cited by 0position: contributordoi
Reply to Comment on the Effect of Semaglutide and GLP-1 RAs on Risk of Nonarteritic Anterior Ischemic Optic Neuropathy
American Journal of Ophthalmology 2025cited by 0position: contributordoi
TENAYA and LUCERNE
Ophthalmology 2024cited by 161position: middledoi
Faricimab for neovascular age-related macular degeneration and diabetic macular edema: from preclinical studies to phase 3 outcomes
Graefe s Archive for Clinical and Experimental Ophthalmology 2024cited by 31position: middledoi
Changes in Prevalence of Idiopathic Intracranial Hypertension in the United States Between 2015 and 2022, Stratified by Sex, Race, and Ethnicity.
2024cited by 26position: contributordoi
Long-term Treatment Patterns for Diabetic Macular Edema
Ophthalmology Retina 2024cited by 18position: contributordoi
Aqueous humour interleukin-6 and vision outcomes with anti-vascular endothelial growth factor therapy
Eye 2024cited by 13position: middledoi
Anti-VEGF and steroid combination therapy relative to anti-VEGF mono therapy for the treatment of refractory DME: A systematic review of efficacy and meta-analysis of safety.
2024cited by 12position: contributordoi
Characterization and prevalence of ocular comorbidities and risk of legal blindness across the United States.
2024cited by 6position: contributordoi
Long-Term Outcomes in Early versus Limited Response to Anti-VEGF Treatment for Retinal Vein Occlusion
Ophthalmology Retina 2024cited by 6position: contributordoi
Associations between lipid abnormalities and diabetic retinopathy across a large United States national database.
2024cited by 5position: contributordoi
Incidence of ocular pathology following bariatric surgery for with morbid obesity across a large United States National Database.
2024cited by 5position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 49 papers (2019–2026)Charles C. Wykoff · Nune Eye Hospital5 papers (2021–2023)Caroline R. Baumal · Retina Specialists4 papers (2021–2025)Blanche L. Kuo · Cleveland Clinic Cole Eye Institute4 papers (2022–2024)Scott W. Perkins · 3 papers (2024–2024)Mohammad Amin Salehi · McGill University Health Centre3 papers (2023–2024)Katherine E. Talcott · Cleveland Clinic3 papers (2024–2026)Fateme Rezagholi · Qazvin University of Medical Sciences Qazvin Medical School3 papers (2023–2024)Nadia J. Abbass · University School3 papers (2025–2026)Hejin Jeong · Cleveland Clinic3 papers (2024–2026)Sonia Kim · Case Western Reserve University3 papers (2026–2026)Jeffrey Chu · University School3 papers (2024–2025)Peter K. Kaiser · Cleveland Clinic3 papers (2020–2022)Mohit Bhandari · McMaster University2 papers (2022–2022)David C. Kaelber · Center for Rheumatology2 papers (2025–2025)Jacqueline K. Shaia · Eastern Virginia Medical School2 papers (2024–2025)Grant L. Hom · University Hospitals of Cleveland2 papers (2020–2020)Lucas W. Rowe · Indiana University2 papers (2026–2026)Fabiana Q. Silva · Regeneron (United States)2 papers (2025–2026)Raj K. Maturi · Elsevier, Inc.2 papers (2026–2026)